医学
内科学
心脏病学
经皮冠状动脉介入治疗
传统PCI
罪魁祸首
心肌梗塞
磁共振成像
逻辑回归
ST段
放射科
作者
Shingo Ota,Tsuyoshi Nishiguchi,Akira Taruya,Takashi Tanimoto,Yasushi Ino,Yosuke Katayama,Yuichi Ozaki,Keisuke Satogami,Atsushi Tanaka
标识
DOI:10.1016/j.jjcc.2022.06.003
摘要
Abstract
Background
Hyperglycemia at admission and intramyocardial hemorrhage (IMH) are associated with poor prognosis in patients with ST-segment elevation myocardial infarction (STEMI). Little is known about the relationship between glucose levels at admission and IMH. The association between matrix metalloproteinase-9 (MMP-9), which plays an important role in the development of IMH, and hyperglycemia is also unknown. This study aimed to investigate the relationship between hyperglycemia at admission and IMH in patients with STEMI. Methods
We enrolled 174 patients with first STEMI who underwent primary percutaneous coronary intervention (PCI) and cardiovascular magnetic resonance (CMR) imaging. T2-weighted imaging and late gadolinium enhancement (LGE)-CMR were performed to detect IMH and microvascular obstruction (MVO), respectively. Two patient groups were created: IMH group and non-IMH group. MMP-9 levels were measured in the culprit coronary arteries of 13 patients. Results
Glucose level at admission and the value of glycosylated hemoglobin were higher in the IMH group than in the non-IMH group [IMH group vs. non-IMH group; 208.5 (157.8–300.5) mg/dL vs. 157.0 (128.8–204.3) mg/dL, p < 0.001, and 6.2 (5.7–7.5) % vs. 5.8 (5.4–6.6) %, p = 0.030, respectively]. A multivariable logistic regression analysis revealed that only admission glucose level was an independent predictor of IMH (OR: 1.012; 95 % CI: 1.005–1.020, p = 0.001). The MMP-9 levels in patients with IMH were higher than those in patients without IMH [256.0 (161.0–396.0) ng/mL vs. 73.5 (49.5–131.0) ng/mL, p = 0.040]. There was a moderate positive correlation between glucose levels at admission and MMP-9 levels (r = 0.600, p = 0.030). Conclusions
Hyperglycemia at admission is associated with the occurrence of IMH in patients with STEMI.
科研通智能强力驱动
Strongly Powered by AbleSci AI